Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 22 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 10369208

    Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  2. US 10363301

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  3. US 10363294

    Yeast-brachyury immunotherapeutic compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  4. US 10363286

    Peptide inhibition of CCR3-mediated diseases or conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  5. US 10358481

    Engineered antibody constant domain molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  6. US 10351587

    Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  7. US 10350273

    Treatment of hormonal disorders of growth

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  8. US 10350312

    Magnetic microstructures for magnetic resonance imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  9. US 10351532

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  10. US 10342871

    Compositions containing nucleosides and manganese and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  11. US 10335423

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  12. US 10335426

    N-acetyl mannosammine as a therapeutic agent

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  13. US 10335478

    Avirulent, immunogenic flavivirus chimeras

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  14. US 10329339

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  15. US 10329259

    Pyrazole derivatives and their use as cannabinoid receptor mediators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  16. US 10322146

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  17. US 10323083

    Agents that specifically bind matrilin-3 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  18. US 10314900

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  19. US 10314924

    RPGR gene therapy for retinitis pigmentosa

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  20. US 10316289

    Methods of producing T memory stem cell populations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  21. US 10308591

    Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  22. US 10307469

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  23. US 10307476

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  24. US 10300115

    Methods and compositions for modulating immune tolerance

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.